These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32719402)

  • 21. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L; Qiao Y; Luo J; Huang R; Xiao Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity.
    Cameron SJ; Lewis KE; Huws SA; Lin W; Hegarty MJ; Lewis PD; Mur LA; Pachebat JA
    PLoS One; 2016; 11(2):e0149095. PubMed ID: 26872143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
    Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
    Madapoosi SS; Cruickshank-Quinn C; Opron K; Erb-Downward JR; Begley LA; Li G; Barjaktarevic I; Barr RG; Comellas AP; Couper DJ; Cooper CB; Freeman CM; Han MK; Kaner RJ; Labaki W; Martinez FJ; Ortega VE; Peters SP; Paine R; Woodruff P; Curtis JL; Huffnagle GB; Stringer KA; Bowler RP; Esther CR; Reisdorph N; Huang YJ;
    Am J Respir Crit Care Med; 2022 Aug; 206(4):427-439. PubMed ID: 35536732
    [No Abstract]   [Full Text] [Related]  

  • 25. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.
    Lal CV; Kandasamy J; Dolma K; Ramani M; Kumar R; Wilson L; Aghai Z; Barnes S; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L810-L815. PubMed ID: 30113227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi'omics profiling.
    Jude MS; Yang CX; Filho FSL; Hernandez Cordero AI; Yang J; Shaipanich T; Li X; Lin D; MacIsaac J; Kobor MS; Sinha S; Nislow C; Singh A; Lam W; Lam S; Guillemi S; Harris M; Montaner J; Ng RT; Carlsten C; Paul Man SF; Sin DD; Leung JM
    Respir Res; 2023 May; 24(1):124. PubMed ID: 37143066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study.
    Casadevall C; Quero S; Millares L; Faner R; Cosío BG; Peces-Barba G; Castro-Acosta A; Montón C; Palou A; Pascual-Guardia S; Agustí A; Gea J; Monsó E; On Behalf Of The Biomepoc Group
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood microbial signatures in current and former smokers.
    Morrow JD; Castaldi PJ; Chase RP; Yun JH; Lee S; Liu YY; Hersh CP
    Sci Rep; 2021 Oct; 11(1):19875. PubMed ID: 34615932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
    Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
    Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Metagenomics of the Bronchial Microbiome in COPD.
    Millares L; Pérez-Brocal V; Ferrari R; Gallego M; Pomares X; García-Núñez M; Montón C; Capilla S; Monsó E; Moya A
    PLoS One; 2015; 10(12):e0144448. PubMed ID: 26632844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection.
    Kayongo A; Bartolomaeus TUP; Birkner T; Markó L; Löber U; Kigozi E; Atugonza C; Munana R; Mawanda D; Sekibira R; Uwimaana E; Alupo P; Kalyesubula R; Knauf F; Siddharthan T; Bagaya BS; Kateete DP; Joloba ML; Sewankambo NK; Jjingo D; Kirenga B; Checkley W; Forslund SK
    Microbiol Spectr; 2023 Feb; 11(2):e0213921. PubMed ID: 36790203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applying Next-Generation Sequencing and Multi-Omics in Chronic Obstructive Pulmonary Disease.
    Tiew PY; Meldrum OW; Chotirmall SH
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
    Luo L; Tang J; Du X; Li N
    Respir Med; 2024; 225():107586. PubMed ID: 38460708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
    Huang JT; Cant E; Keir HR; Barton AK; Kuzmanova E; Shuttleworth M; Pollock J; Finch S; Polverino E; Bottier M; Dicker AJ; Shoemark A; Chalmers JD
    Am J Respir Crit Care Med; 2022 Aug; 206(4):417-426. PubMed ID: 35436182
    [No Abstract]   [Full Text] [Related]  

  • 37. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.
    Tiew PY; Mac Aogáin M; Chotirmall SH
    Curr Opin Pulm Med; 2022 Mar; 28(2):121-133. PubMed ID: 34839338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral microbial dysbiosis in patients with periodontitis and chronic obstructive pulmonary disease.
    Liu S; Xie G; Chen M; He Y; Yu W; Chen X; Mao W; Liu N; Zhang Y; Chang Q; Qiao Y; Ma X; Xue J; Jin M; Guo S; Hou Y; Gao Z
    Front Cell Infect Microbiol; 2023; 13():1121399. PubMed ID: 36844402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability.
    Dang X; Kang Y; Wang X; Cao W; Li M; He Y; Pan X; Ye K; Xu D
    Front Microbiol; 2022; 13():1037037. PubMed ID: 36532417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.